Brief: Ascelia Pharma Says To Focus On Bringing Orviglance Through Regulatory Approval Process
16/05/2024 06:37
May 16 (Reuters) - Ascelia Pharma AB ACELP.ST :
* WILL NOW FOCUS ON BRINGING ORVIGLANCE THROUGH REGULATORY
SUBMISSION AND APPROVAL PROCESS
* WILL CONTINUE TO ADVANCE LAUNCH READINESS AND DIALOGUE
WITH
POTENTIAL COMMERCIALIZATION PARTNERS ON ORVIGLANCE
* SUBMISSION OF NDA TO US FDA TO OBTAIN REGULATORY APPROVAL
EXPECTED BY MID-2025
Source text for Eikon: ID:nMFN9tqqgZ
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))